(Q43855460)

27 November 2017

title

Lamotrigine induced selective changes in 5-HT(1A) receptor mediated response in rat brain (English)

1 reference

27 November 2017

1 reference

K Y Vinod

1

1 reference

27 November 2017

M N Subhash

series ordinal

2

1 reference

27 November 2017

publication date

1 April 2002

1 reference

Neurochemistry International

27 November 2017

published in

1 reference

27 November 2017

volume

40

1 reference

27 November 2017

issue

4

1 reference

27 November 2017

page(s)

315-319

1 reference

Lamotrigine in the treatment of bipolar depression

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Female Genital Disorder as Adverse Symptom of Lamotrigine Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Lamotrigine in the treatment of schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Conventional and new antidepressant drugs in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Novel anticonvulsants: a new generation of mood stabilizers?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

A proposed new nomenclature for 5-HT receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Serotonergic basis of antipsychotic drug effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

A practical computer-based approach to the analysis of radioligand binding experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Beyond lithium in the treatment of bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Effects of lamotrigine on the 5-HT1A receptor function in healthy human males

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Antiglutamatergic therapy in Alzheimer's disease--effects of lamotrigine. Short communication

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Separation of cyclic GMP and cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2801%2900088-2

7 January 2021

10.1016/S0197-0186(01)00088-2

Identifiers

DOI

1 reference

27 November 2017

1 reference